Cannabis for Cancer and Pain
As medicinal cannabis is now available in 25 states, physicians should become aware of the biologic activities of various cannabinoids and other plant chemicals, sativa vs indica, and the pharmacokinetics of ingested and inhaled cannabis to best advise cancer patients seeking its use for cancer care and pain management. Dr Abrams guides us through his significant research and experience in cannabis for cannabis and pain care.
Connecting the Dots to Evidence-Based Dispensary Care
Tikun Olam's Nurses clinic in Israel is led by Inbal Sikorin since 2009, specializing in consulting medical cannabis to patients of all ages, 3 months old to 102, suffering from different and complicated ailments. Since the Clinic's establishment it has set to document according to international standards of data collection patients experience before Medical Cannabis use, a month after and six months after the start of the treatment. This has provided Tikun Olam ltd. with the largest documented and analyzed accumulated patient data in the world.
Cannabinoids as potential anticancer agents
Current understanding of cannabinoids as antitumour agents, focusing on recent discoveries about their molecular mechanisms of action. Dr Velasco will discuss both his research and applying cannabis therapies to conventional treatments.
Clinical Application of Cannabinoids and Terpenes
For over five years, Ms Gordon has been collecting cannabis patient data using specific dosing protocols across a myriad of diseases. These patients have been tracked for efficacy utilizing various qualitative and quantitative techniques. Discussion includes case studies, including outcomes.
How Cannabis Works (Pharmacology) and What the Body Does with it (Pharmacokinetics)
The endocannabinoid system is the largest receptor system in the brain and nervous system. What happens when that edible, joint, or concentrate connects with it? Important class for new cannabis physicians and medical marijuana industry pros.
Modern Practice Perspectives on Traditional Endocannabinoid Medicines
In the near future, we will use laboratory science to match strains to patients and ailments. Really. Dr Jeffrey Block shows us a future where plant cannabinoids are mapped to human endocannabinoid systems.
Medical Marijuana: Challenges and Opportunities for Pharmacists
When we talk about cannabis, we mention doctors, researchers, patients, and budtenders. Yet, it's pharmacists who routinely top lists of America's Most Trusted Health Professionals. Joseph Friedman, R.Ph, discusses the pharmacist's role in the field of Medical Marijuana, and shows us How They Do It in Illinois.
The Endocannabinoid System: Looking Back and Ahead
In the 1960's, a young researcher in Israel named Raphael Mechoulam isolated THC tetrahydrocannabinol from cannabis and explained the mechanism of activity - and psychoactivity - of the plant. A lifetime of achievements in science followed. Who better to lead us into the future of cannabinoid science than Mechoulam himself? Now in his late 80's, the tireless Professor speaks to us live, via Skype.
Is Evidence-based Medicine Ready for Medical Marijuana?
What happens when the conventional medical model of a single, synthesized chemical compound used in measured doses for a single disease encounters the entourage effect? Worlds collide. Jack McCue, MD helps clinicians find common ground between two different paths towards the same goal.
Cancer, Hematopoietic Stem Cell Transplantation, and Cannabis
University of Colorado alumnus Reuven Or MD, PhD returns to our beloved Rocky Mountains to share his work with us. Dr Or's team at Hadassah University Medical Center in Jerusalem, Israel has lead the world in new therapy models for improving bone marrow transplantation outcomes. The role of cannabis in the immune system, and how that applies to transplant therapies is a session not to be missed.